{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["behavioral disorders", "depression", "forced swim test", "natural products", "phenolic acids", "phenylpropanoids", "plants", "tail suspension test"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31817569", "DateCompleted": {"Year": "2020", "Month": "05", "Day": "04"}, "DateRevised": {"Year": "2021", "Month": "02", "Day": "24"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "12", "Day": "06"}], "Language": ["eng"], "ELocationID": ["4469", "10.3390/molecules24244469"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "24", "Issue": "24", "PubDate": {"Year": "2019", "Month": "Dec", "Day": "06"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Antidepressant Potential of Cinnamic Acids: Mechanisms of Action and Perspectives in Drug Development.", "Abstract": {"AbstractText": ["Depression is a health problem that compromises the quality of life of the world's population. It has different levels of severity and a symptomatic profile that affects social life and performance in work activities, as well as a high number of deaths in certain age groups. In the search for new therapeutic options for the treatment of this behavioral disorder, the present review describes studies on antidepressant activity of cinnamic acids, which are natural products found in medicinal plants and foods. The description of the animal models used and the mechanisms of action of these compounds are discussed."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departament of Pharmacy, Federal University of Sergipe, S\u00e3o Crist\u00f3v\u00e3o SE 49100-000, Brazil."}], "LastName": "Diniz", "ForeName": "L\u00facio Ricardo Leite", "Initials": "LRL"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departament of Pharmacy, Federal University of Sergipe, S\u00e3o Crist\u00f3v\u00e3o SE 49100-000, Brazil."}], "LastName": "Souza", "ForeName": "Marilia Trindade de Santana", "Initials": "MTS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departament of Pharmaceutical Sciences, Federal University of Para\u00edba, Jo\u00e3o Pessoa PB 58051-970, Brazil."}], "LastName": "Barboza", "ForeName": "Joice Nascimento", "Initials": "JN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology and Pathology, Federal University of Para\u00edba, Jo\u00e3o Pessoa PB 58051-970, Brazil."}], "LastName": "Almeida", "ForeName": "Reinaldo N\u00f3brega de", "Initials": "RN"}, {"Identifier": ["0000-0002-7180-4896"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Departament of Pharmaceutical Sciences, Federal University of Para\u00edba, Jo\u00e3o Pessoa PB 58051-970, Brazil."}], "LastName": "Sousa", "ForeName": "Dami\u00e3o Pergentino de", "Initials": "DP"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antidepressive Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Cinnamates"}, {"RegistryNumber": "140-10-3", "NameOfSubstance": "cinnamic acid"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Antidepressive Agents"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Cinnamates"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Depression"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": [], "DescriptorName": "Drug Development"}], "CoiStatement": "The authors declare no conflict of interest"}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Peres M.F.P., Mercante J.P.P., Tobo P.R., Kamei H., Bigal M.E. Anxiety and depression symptoms and migraine: A symptom-based approach research. J. Headache Pain. 2017;18:37. doi: 10.1186/s10194-017-0742-1.", "ArticleIdList": ["10.1186/s10194-017-0742-1", "PMC5360747", "28324317"]}, {"Citation": "Smith K. Mental health: A world of depression. Nature. 2014;515:181. doi: 10.1038/515180a.", "ArticleIdList": ["10.1038/515180a", "25391942"]}, {"Citation": "Bravender T. Mental Disorders and Learning Disabilities in Children and Adolescents: Depression in Adolescents. FP Essent. 2018;475:30.", "ArticleIdList": ["30556689"]}, {"Citation": "Wang S., Blazer D.G. Depression and cognition in the elderly. Annu Rev. Clin. Psychol. 2015;11:331. doi: 10.1146/annurev-clinpsy-032814-112828.", "ArticleIdList": ["10.1146/annurev-clinpsy-032814-112828", "25581234"]}, {"Citation": "Gournellis R., Tournikioti K., Touloumi G., Thomadakis C., Michalopoulou P.G., Michopoulos I., Christodoulou C., Papadopoulou A., Douzenis A. Psychotic (delusional) depression and completed suicide: A systematic review and meta-analysis. Ann. Gen. Psychiatry. 2018;17:39. doi: 10.1186/s12991-018-0207-1.", "ArticleIdList": ["10.1186/s12991-018-0207-1", "PMC6150953", "30258483"]}, {"Citation": "Hawton K., Casanas I.C.C., Haw C., Saunders K. Risk factors for suicide in individuals with depression: A systematic review. J. Affect. Disord. 2013;147:17. doi: 10.1016/j.jad.2013.01.004.", "ArticleIdList": ["10.1016/j.jad.2013.01.004", "23411024"]}, {"Citation": "Krishnan V., Nestler E.J. The molecular neurobiology of depression. Nature. 2008;455:894. doi: 10.1038/nature07455.", "ArticleIdList": ["10.1038/nature07455", "PMC2721780", "18923511"]}, {"Citation": "Peng G.J., Tian J.S., Gao X.X., Zhou Y.Z., Qin X.M. Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression. Curr. Neuropharmacol. 2015;13:514. doi: 10.2174/1570159X1304150831120428.", "ArticleIdList": ["10.2174/1570159X1304150831120428", "PMC4790409", "26412071"]}, {"Citation": "Ruiz N.A.L., Del Angel D.S., Olguin H.J., Silva M.L. Neuroprogression: The hidden mechanism of depression. Neuropsychiatr. Dis. Treat. 2018;14:2837. doi: 10.2147/NDT.S177973.", "ArticleIdList": ["10.2147/NDT.S177973", "PMC6214587", "30464468"]}, {"Citation": "Uchida S., Yamagata H., Seki T., Watanabe Y. Epigenetic mechanisms of major depression: Targeting neuronal plasticity. Psychiatry Clin. Neurosci. 2018;72:212. doi: 10.1111/pcn.12621.", "ArticleIdList": ["10.1111/pcn.12621", "29154458"]}, {"Citation": "Liu C.H., Zhang G.Z., Li B., Li M., Woelfer M., Walter M., Wang L. Role of inflammation in depression relapse. J. Neuroinflammation. 2019;16:90. doi: 10.1186/s12974-019-1475-7.", "ArticleIdList": ["10.1186/s12974-019-1475-7", "PMC6472093", "30995920"]}, {"Citation": "Reus G.Z., Silva R.H., de Moura A.B., Presa J.F., Abelaira H.M., Abatti M., Vieira A., Pescador B., Michels M., Ignacio Z.M., et al. Early Maternal Deprivation Induces Microglial Activation, Alters Glial Fibrillary Acidic Protein Immunoreactivity and Indoleamine 2,3-Dioxygenase during the Development of Offspring Rats. Mol. Neurobiol. 2019;56:1096. doi: 10.1007/s12035-018-1161-2.", "ArticleIdList": ["10.1007/s12035-018-1161-2", "29873040"]}, {"Citation": "Oglodek E.A. Changes in the concentrations of inflammatory and oxidative status biomediators (MIP-1 alpha, PMN elastase, MDA, and IL-12) in depressed patients with and without posttraumatic stress disorder. Pharmacol Rep. 2018;70:110. doi: 10.1016/j.pharep.2017.08.008.", "ArticleIdList": ["10.1016/j.pharep.2017.08.008", "29339257"]}, {"Citation": "Stanners M.N., Barton C.A., Shakib S., Winefield H.R. Depression diagnosis and treatment amongst multimorbid patients: A thematic analysis. BMC Fam. Pract. 2014;15:124. doi: 10.1186/1471-2296-15-124.", "ArticleIdList": ["10.1186/1471-2296-15-124", "PMC4074384", "24947875"]}, {"Citation": "Blackburn T.P. Depressive disorders: Treatment failures and poor prognosis over the last 50 years. Pharmacol. Res. Perspect. 2019;7:e00472. doi: 10.1002/prp2.472.", "ArticleIdList": ["10.1002/prp2.472", "PMC6498411", "31065377"]}, {"Citation": "Hollon S.D., Cohen Z.D., Singla D.R., Andrews P.W. Recent Developments in the Treatment of Depression. Behav. Ther. 2019;50:257. doi: 10.1016/j.beth.2019.01.002.", "ArticleIdList": ["10.1016/j.beth.2019.01.002", "30824244"]}, {"Citation": "L\u00f3pez-Rubalcava C., Estrada-Camarena E. Mexican medicinal plants with anxiolytic or antidepressant activity: Focus on preclinical research. J. Ethnopharmacol. 2016;20:377\u2013391.", "ArticleIdList": ["27021688"]}, {"Citation": "Guzman J.D., Mortazavi P.N., Munshi T., Evangelopoulos D., Mchugh T.D., Gibbons S., Malkinson J., Bhakta S. 2-Hydroxy-substituted cinnamic acids and acetanilides are selective growth inhibitors of Mycobacterium tuberculosis. MedChemComm. 2014;5:47\u201350. doi: 10.1039/C3MD00251A.", "ArticleIdList": ["10.1039/C3MD00251A"]}, {"Citation": "Tian Y., Liu W., Lu Y., Wang Y., Chen X., Bai S., Zhao Y., He T., Lao F., Shang Y., et al. Naturally Occurring Cinnamic Acid Sugar Ester Derivatives. Molecules. 2016;21:1402. doi: 10.3390/molecules21101402.", "ArticleIdList": ["10.3390/molecules21101402", "PMC6273327", "27783048"]}, {"Citation": "de C\u00e1ssia D.S.E.S., Andrade L.N., Dos Reis B.D.O.R., de Sousa D.P. A review on anti-inflammatory activity of phenylpropanoids found in essential oils. Molecules. 2014;19:1459\u20131480. doi: 10.3390/molecules19021459.", "ArticleIdList": ["10.3390/molecules19021459", "PMC6270723", "24473208"]}, {"Citation": "Sova M. Antioxidant and antimicrobial activities of cinnamic acid derivatives. Mini Rev. Med. Chem. 2012;12:749\u2013767. doi: 10.2174/138955712801264792.", "ArticleIdList": ["10.2174/138955712801264792", "22512578"]}, {"Citation": "Anantharaju P.G., Gowda P.C., Vimalambike M.G., Madhunapantula S.V. An overview on the role of dietary phenolics for the treatment of cancers. Nutr. J. 2016;15:99. doi: 10.1186/s12937-016-0217-2.", "ArticleIdList": ["10.1186/s12937-016-0217-2", "PMC5131407", "27903278"]}, {"Citation": "Alam M.A., Subhan N., Hossain H., Hossain M., Reza H.M., Rahman M.M., Ullah M.O. Hydroxycinnamic acid derivatives: A potential class of natural compounds for the management of lipid metabolism and obesity. Nutr. Metab. 2016;13:27. doi: 10.1186/s12986-016-0080-3.", "ArticleIdList": ["10.1186/s12986-016-0080-3", "PMC4827240", "27069498"]}, {"Citation": "Liu P., Hu Y., Guo D.H., Wang D.X., Tu H.H., Ma L., Xie T.T., Kong L.Y. Potential antidepressant properties of Radix polygalae (Yuan Zhi) Phytomedicine. 2010;17:794\u2013799. doi: 10.1016/j.phymed.2010.01.004.", "ArticleIdList": ["10.1016/j.phymed.2010.01.004", "20541923"]}, {"Citation": "Szwajgier D., Borowiec K., Pustelniak K. The Neuroprotective Effects of Phenolic Acids: Molecular Mechanism of Action. Nutrients. 2017;9:477. doi: 10.3390/nu9050477.", "ArticleIdList": ["10.3390/nu9050477", "PMC5452207", "28489058"]}, {"Citation": "Magoulas G.E., Papaioannou D. Bioinspired syntheses of dimeric hydroxycinnamic acids (lignans) and hybrids, using phenol oxidative coupling as key reaction, and medicinal significance thereof. Molecules. 2014;19:19769. doi: 10.3390/molecules191219769.", "ArticleIdList": ["10.3390/molecules191219769", "PMC6271182", "25460307"]}, {"Citation": "Bialecka-Florjanczyk E., Fabiszewska A., Zieniuk B. Phenolic Acids Derivatives-Biotechnological Methods of Synthesis and Bioactivity. Curr. Pharm. Biotechnol. 2018;19:1098. doi: 10.2174/1389201020666181217142051.", "ArticleIdList": ["10.2174/1389201020666181217142051", "30556498"]}, {"Citation": "Wu S., Zhang Y., Ren F., Qin Y., Liu J., Liu J., Wang Q., Zhang H. Structure-affinity relationship of the interaction between phenolic acids and their derivatives and beta-lactoglobulin and effect on antioxidant activity. Food Chem. 2018;245:613. doi: 10.1016/j.foodchem.2017.10.122.", "ArticleIdList": ["10.1016/j.foodchem.2017.10.122", "29287417"]}, {"Citation": "Dludla P.V., Nkambule B.B., Jack B., Mkandla Z., Mutize T., Silvestri S., Orlando P., Tiano L., Louw J., Mazibuko-Mbeje S.E. Inflammation and Oxidative Stress in an Obese State and the Protective Effects of Gallic Acid. Nutrients. 2019;11:23. doi: 10.3390/nu11010023.", "ArticleIdList": ["10.3390/nu11010023", "PMC6356415", "30577684"]}, {"Citation": "Oliviero F., Scanu A., Zamudio-Cuevas Y., Punzi L., Spinella P. Anti-inflammatory effects of polyphenols in arthritis. J. Sci. Food Agric. 2018;98:1653. doi: 10.1002/jsfa.8664.", "ArticleIdList": ["10.1002/jsfa.8664", "28886220"]}, {"Citation": "Gaspar A., Garrido E.M., Esteves M., Quezada E., Milhazes N., Garrido J., Borges F. New insights into the antioxidant activity of hydroxycinnamic acids: Synthesis and physicochemical characterization of novel halogenated derivatives. Eur. J. Med. Chem. 2009;44:2092. doi: 10.1016/j.ejmech.2008.10.027.", "ArticleIdList": ["10.1016/j.ejmech.2008.10.027", "19058883"]}, {"Citation": "Razzaghi-Asl N., Garrido J., Khazraei H., Borges F., Firuzi O. Antioxidant properties of hydroxycinnamic acids: A review of structure- activity relationships. Curr. Med. Chem. 2013;20:4436. doi: 10.2174/09298673113209990141.", "ArticleIdList": ["10.2174/09298673113209990141", "23834166"]}, {"Citation": "Castagne V., Moser P., Roux S., Porsolt R.D. Rodent models of depression: Forced swim and tail suspension behavioral despair tests in rats and mice. Curr. Protoc. Neurosci. 2011;55:8\u201310. doi: 10.1002/0471142301.ns0810as55.", "ArticleIdList": ["10.1002/0471142301.ns0810as55", "21462162"]}, {"Citation": "Yan H.C., Cao X., Das M., Zhu X.H., Gao T.M. Behavioral animal models of depression. Neurosci. Bull. 2010;26:327. doi: 10.1007/s12264-010-0323-7.", "ArticleIdList": ["10.1007/s12264-010-0323-7", "PMC5552573", "20651815"]}, {"Citation": "Abelaira H.M., Reus G.Z., Quevedo J. Animal models as tools to study the pathophysiology of depression. Braz. J. Psychiatry. 2013;35:S112\u2013S120. doi: 10.1590/1516-4446-2013-1098.", "ArticleIdList": ["10.1590/1516-4446-2013-1098", "24271223"]}, {"Citation": "Nakazawa T., Yasuda T., Ueda J., Ohsawa K. Antidepressant-like effects of apigenin and 2, 4, 5-trimethoxycinnamic acid from Perilla frutescens in the forced swimming test. Biol. Pharm. Bull. 2003;26:474\u2013480. doi: 10.1248/bpb.26.474.", "ArticleIdList": ["10.1248/bpb.26.474", "12673028"]}, {"Citation": "Leem Y.H., Oh S. 3, 4, 5-Trimethoxycinnamin acid ameliorates restraint stress-induced anxiety and depression. Neurosci. Lett. 2015;585:54\u201359. doi: 10.1016/j.neulet.2014.11.016.", "ArticleIdList": ["10.1016/j.neulet.2014.11.016", "25445378"]}, {"Citation": "Takeda H., Tsuji M., Inazu M., Egashira T., Matsumiya T. Rosmarinic acid and caffeic acid produce antidepressive-like effect in the forced swimming test in mice. Eur. J. Pharmacol. 2002;449:261\u2013267. doi: 10.1016/S0014-2999(02)02037-X.", "ArticleIdList": ["10.1016/S0014-2999(02)02037-X", "12167468"]}, {"Citation": "Takeda H., Tsuji M., Miyamoto J., Masuya J., Iimori M., Matsumiya T. Caffeic acid produces antidepressive-and/or anxiolytic-like effects through indirect modulation of the \u03b11A-adrenoceptor system in mice. Neuroreport. 2003;14:1067\u20131070. doi: 10.1097/01.wnr.0000073427.02536.b0.", "ArticleIdList": ["10.1097/01.wnr.0000073427.02536.b0", "12802204"]}, {"Citation": "Takeda H., Tsuji M., Yamada T., Masuya J., Matsushita K., Tahara M., Matsumiya T., Limore M., Matsumiya T. Caffeic acid attenuates the decrease in cortical BDNF mRNA expression induced by exposure to forced swimming stress in mice. Eur. J. Pharmacol. 2006;534:115\u2013121. doi: 10.1016/j.ejphar.2006.01.026.", "ArticleIdList": ["10.1016/j.ejphar.2006.01.026", "16497295"]}, {"Citation": "Dzitoyeva S., Imbesi M., Uz T., Dimitrijevic N., Manev H., Manev R. Caffeic acid attenuates the decrease of cortical BDNF transcript IV mRNA induced by swim stress in wild-type but not in 5-lipoxygenase-deficient mice. J. Neural Transm. Suppl. 2008;115:823\u2013827. doi: 10.1007/s00702-008-0034-7.", "ArticleIdList": ["10.1007/s00702-008-0034-7", "18305891"]}, {"Citation": "Huang D., Zhang L., Yang J.Q., Luo Y., Cui T., Du T.T., Jiang X.H. Evaluation on monoamine neurotransmitters changes in depression rats given with sertraline, meloxicam or/and caffeic acid. Genes Dis. 2019;6:167\u2013175. doi: 10.1016/j.gendis.2018.05.005.", "ArticleIdList": ["10.1016/j.gendis.2018.05.005", "PMC6545449", "31193976"]}, {"Citation": "Zdunska K., Dana A., Kolodziejczak A., Rotsztejn H. Antioxidant Properties of Ferulic Acid and Its Possible Application. Skin Pharmacol. Physiol. 2018;31:332. doi: 10.1159/000491755.", "ArticleIdList": ["10.1159/000491755", "30235459"]}, {"Citation": "Zeni A.L.B., Zomkowski A.D.E., Maraschin M., Rodrigues A.L.S., Tasca C.I. Ferulic acid exerts antidepressant-like effect in the tail suspension test in mice: Evidence for the involvement of the serotonergic system. Eur. J. Pharmacol. 2012;679:68\u201374. doi: 10.1016/j.ejphar.2011.12.041.", "ArticleIdList": ["10.1016/j.ejphar.2011.12.041", "22266492"]}, {"Citation": "Zeni A.L.B., Camargo A., Dalmagro A.P. Ferulic acid reverses depression-like behavior and oxidative stress induced by chronic corticosterone treatment in mice. Steroids. 2017;125:131\u2013136. doi: 10.1016/j.steroids.2017.07.006.", "ArticleIdList": ["10.1016/j.steroids.2017.07.006", "28733038"]}, {"Citation": "Chen J., Lin D., Zhang C., Li G., Zhang N., Ruan L., Yan K., Li J., Yu X., Xie X., et al. Antidepressant-like effects of ferulic acid: Involvement of serotonergic and norepinergic systems. Metab. Brain Dis. 2015;30:129\u2013136. doi: 10.1007/s11011-014-9635-z.", "ArticleIdList": ["10.1007/s11011-014-9635-z", "25483788"]}, {"Citation": "Zhang Y.J., Huang X., Wang Y., Xie Y., Qiu X.J., Ren P., Gao L.C., Zhou H.H., Zhange H.Y., Qiao M.Q. Ferulic acid-induced anti-depression and prokinetics similar to Chaihu\u2013Shugan\u2013San via polypharmacology. Brain Res. Bull. 2011;86:222\u2013228. doi: 10.1016/j.brainresbull.2011.07.002.", "ArticleIdList": ["10.1016/j.brainresbull.2011.07.002", "21791239"]}, {"Citation": "Sasaki K., Iwata N., Ferdousi F., Isoda H. Antidepressant-Like Effect of Ferulic Acid via Promotion of Energy Metabolism Activity. Mol. Nutr. Food Res. 2019;63:1900327. doi: 10.1002/mnfr.201900327.", "ArticleIdList": ["10.1002/mnfr.201900327", "PMC6790570", "31394019"]}, {"Citation": "Lenzi J., Rodrigues A.F., de Sousa R\u00f3s A., de Castro B.B., de Lima D.D., Dal Magro D.D., Zeni A.L.B. Ferulic acid chronic treatment exerts antidepressant-like effect: Role of antioxidant defense system. Metab. Brain Dis. 2015;30:1453\u20131463. doi: 10.1007/s11011-015-9725-6.", "ArticleIdList": ["10.1007/s11011-015-9725-6", "26340979"]}, {"Citation": "Li G., Ruan L., Chen R., Wang R., Xie X., Zhang M., Chen L., Yan Q., Reed M., Chen J., et al. Synergistic antidepressant-like effect of ferulic acid in combination with piperine: Involvement of monoaminergic system. Metab. Brain Dis. 2015;30:1505\u20131514. doi: 10.1007/s11011-015-9704-y.", "ArticleIdList": ["10.1007/s11011-015-9704-y", "PMC4795470", "26220010"]}, {"Citation": "Liu Y.M., Hu C.Y., Shen J.D., Wu S.H., Li Y.C., Yi L.T. Elevation of synaptic protein is associated with the antidepressant-like effects of ferulic acid in a chronic model of depression. Physiol. Behav. 2017;169:184\u2013188. doi: 10.1016/j.physbeh.2016.12.003.", "ArticleIdList": ["10.1016/j.physbeh.2016.12.003", "27940143"]}, {"Citation": "Zheng X., Cheng Y., Chen Y., Yue Y., Li Y., Xia S., Li Y., Deng H., Zang J., Cao Y. Ferulic Acid Improves Depressive-Like Behavior in Prenatally-Stressed Offspring Rats via Anti-Inflammatory Activity and HPA Axis. Int. J. Mol. Sci. 2019;20:493. doi: 10.3390/ijms20030493.", "ArticleIdList": ["10.3390/ijms20030493", "PMC6387299", "30678337"]}, {"Citation": "Lee S., Kim H.B., Hwang E.S., Kim E.S., Kim S.S., Jeon T.D., Song M., Li J.S., Chung M.C., Maeng S., et al. Antidepressant-like effects of p-coumaric acid on LPS-induced depressive and inflammatory changes in rats. Exp. Neurobiol. 2018;27:189\u2013199. doi: 10.5607/en.2018.27.3.189.", "ArticleIdList": ["10.5607/en.2018.27.3.189", "PMC6050412", "30022870"]}, {"Citation": "Barauna S.C., Delwing-Dal M.D., Brueckheimer M.B., Maia T.P., Sala G.A.B.N., D\u00f6hler A.W., Harger M.C., de Melo D.F.M., de Gasper A.L., Alberton M.D., et al. Antioxidant and antidepressant-like effects of Eugenia catharinensis D. Legrand in an animal model of depression induced by corticosterone. Metab. Brain Dis. 2018;33:1985\u20131994. doi: 10.1007/s11011-018-0306-3.", "ArticleIdList": ["10.1007/s11011-018-0306-3", "30136092"]}, {"Citation": "Adeoluwa A.O., Aderibigbe O.A., Agboola I.O., Olonode T.E., Ben-Azu B. Butanol Fraction of Olax subscorpioidea Produces Antidepressant Effect: Evidence for the Involvement of Monoaminergic Neurotransmission. Drug Res. (Stuttg). 2019;69:53\u201360. doi: 10.1055/a-0651-7939.", "ArticleIdList": ["10.1055/a-0651-7939", "30071571"]}, {"Citation": "Pauleti N.N., Mello J., Siebert D.A., Micke G.A., de Albuquerque C.A.C., Alberton M., Barauna S.C. Characterisation of phenolic compounds of the ethyl acetate fraction from Tabernaemontana catharinensis and its potential antidepressant-like effect. Nat. Prod. Res. 2018;32:1987\u20131990. doi: 10.1080/14786419.2017.1359167.", "ArticleIdList": ["10.1080/14786419.2017.1359167", "28764559"]}]}], "History": [{"Year": "2019", "Month": "11", "Day": "15"}, {"Year": "2019", "Month": "11", "Day": "28"}, {"Year": "2019", "Month": "11", "Day": "28"}, {"Year": "2019", "Month": "12", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "12", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "12", "Day": "6"}], "PublicationStatus": "epublish", "ArticleIdList": ["31817569", "PMC6943791", "10.3390/molecules24244469", "molecules24244469"]}}]}